Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB01306
http://purl.obolibrary.org/obo/dinto_DB01306
|
|---|---|
| Preferred Name | insulin aspart |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | insulin aspart
|
|---|---|
| label | insulin aspart
|
| DBSynonym |
aspart
aspart insulin
b28-aspart-insulin
insulin, asp(b28)
ina-x14
insulin x14
See more
See less
|
| ATCCode |
A10AB05
A10AD05
|
| Definition | Insulin aspart is a recombinant, biosynthetic, fast-acting insulin analogue. It has a single amino acid substitution at position B28 where proline is replaced with aspartic acid. This substitution decreases its propensity to form hexamers and gives it a higher rate of absorption following subcutaneous administration compared to native insulin. Insulin aspart is produced in a genetically modified strain of _Saccharomyces cerevisiae_ and harvested from a bioreactor.
|
| has effect |
See more
See less
|
| has pharmacological target | |
| induces | |
| activates | |
| type | |
| AHFScode | 68:20.08
|
| xref |
National Drug Code Directory:0169-7501-11
Wikipedia:http://en.wikipedia.org/wiki/Insulin_aspart
PharmGKB:PA164784029
RxList:http://www.rxlist.com/novolog-drug.htm
Drugs.com:http://www.drugs.com/mtm/insulin-aspart.html
|
| CASRN | 116094-23-6
|
| prefixIRI | obo2:dinto_DB01306
|
| may interact with |
See more
See less
|
| DBBrand |
novolog flexpen
novorapid penfill
novolog
novorapid
novolog penfill
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |